Vertex Pharmaceuticals (NASDAQ: VRTX) is one of the largest biopharma businesses in the world, but you've probably never heard of anyone taking the medications that it makes. Today, Vertex's shares go for around $180. Right now, Vertex has four drugs that are approved for sale, all of which are combinations of molecules it developed to treat cystic fibrosis (CF).
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting